Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Profile of Ultravist in Patients With Different Sexes, Races and From Different Countries/Regions

NCT05428397 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05428397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05428397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Profile of Ultravist in Patients With Different Sexes, Races and From Different Countries/Regions
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
June 30, 2022
Completion date
October 28, 2022
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast enhanced x-ray based examination